Company Filing History:
Years Active: 2010
Title: Innovations in Asthma Therapy by Ching-Jen Yang
Introduction
Ching-Jen Yang is a notable inventor based in Zhongli, Taiwan. He has made significant contributions to the field of asthma therapy through his innovative research and development. His work focuses on utilizing small interfering RNA (siRNA) to inhibit the expression of the acidic mammalian chitinase (AMCase) gene, which plays a crucial role in asthma.
Latest Patents
Ching-Jen Yang holds a patent for the "Development of asthma therapy with rAAV-mediated AMCase shRNA." This invention provides a method for treating asthma in mammals by using siRNA and their carriers to inhibit AMCase gene expression. The composition includes siRNA and a carrier, offering a novel approach to asthma treatment.
Career Highlights
Ching-Jen Yang is affiliated with Ming Chi University of Technology, where he continues to advance his research in respiratory therapies. His dedication to innovation in medical treatments has positioned him as a key figure in the field.
Collaborations
Ching-Jen Yang has collaborated with notable colleagues, including Chao-Lin Liu and Chia-Rui Shen, who contribute to his research efforts and enhance the impact of his work.
Conclusion
Ching-Jen Yang's innovative approach to asthma therapy exemplifies the potential of siRNA technology in medical treatments. His contributions are paving the way for new therapeutic options for asthma patients.